Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
There is a need for countermeasures to mitigate lethal acute radiation syndrome (ARS) and delayed effects of acute radiation exposure (DEARE). In WAG/RijCmcr rats, ARS occurs by 30-days following total body irradiation (TBI), and manifests as potentially lethal gastrointestinal (GI) and hematopoieti...
Main Authors: | Tracy Gasperetti, Tessa Miller, Feng Gao, Jayashree Narayanan, Elizabeth R. Jacobs, Aniko Szabo, George N. Cox, Christie M. Orschell, Brian L. Fish, Meetha Medhora |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.634477/full |
Similar Items
-
Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
by: Tracy Gasperetti, et al.
Published: (2021-08-01) -
Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities
by: Meetha Medhora, et al.
Published: (2021-04-01) -
Wound Trauma Exacerbates Acute, but not Delayed, Effects of Radiation in Rats: Mitigation by Lisinopril
by: Meetha Medhora, et al.
Published: (2020-05-01) -
Classes of Drugs that Mitigate Radiation Syndromes
by: Ewa D. Micewicz, et al.
Published: (2021-05-01) -
Effect of photographs on shopping behavior of consumers
by: James Ravindran Santhakumar, Meetha Nesam
Published: (2018)